Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | GRCEGrace Therapeutics, Inc.FY2022 · Mar |
|---|---|
| Revenue | $100.00M |
| Revenue, yoy | +50,920.4% |
| Net income | $7.79M |
| Net income, yoy | +18.6% |
| Net margin | — |
| Free cash flow | $33.18M |
| FCF margin | — |
| EPS, diluted | $0.47 |
Add another company.